| Jul 2 |
Cheap Stocks To Buy: This Microcap Gold Stock Breaks Out
|
| Jul 1 |
FDA Rejects Rocket's (RCKT) Gene Therapy BLA for Rare Disease
|
| Jun 27 |
FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma
|
| Jun 26 |
AstraZeneca's (AZN) Imfinzi Meets Study Goal in Bladder Cancer
|
| Jun 24 |
FDA Expands argenx's (ARGX) Vyvgart Label to Treat Rare Disorder
|
| Jun 20 |
Vanda Pharmaceuticals And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
|
| Jun 18 |
OVID Slumps 76% on Epilepsy Drug Failing Two Pivotal Studies
|
| Jun 17 |
Has Arcutis Biotherapeutics (ARQT) Outpaced Other Medical Stocks This Year?
|
| Jun 14 |
Wall Street Analysts Think Arcutis Biotherapeutics (ARQT) Could Surge 99.89%: Read This Before Placing a Bet
|
| Jun 13 |
Avidity (RNA) Up 33% on Rare Muscle Disease Study Results
|
